Imagion Biosystems Appendix 4G and Corporate Governance Statement for the financial year ended 31 December 2018 is available. Download Appendix 4G.
Quarterly Activity Report – Quarter ending 31 December 2023
Highlights: Announced positive results from IBI10103 Phase I Study demonstrating safety and clinical feasibility of molecular MRI with MagSense® HER2 Imaging Agent Presented new animal